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Toxicity of Chioroprene,
1,3-Dichlorobutene-2, and
1,4-Dichlorobutene-2
by J. J. Clary*
A review of the toxicity of 1,3-dichlorobutene-2 (1,3-DCB), 1,4-dichlorobutene-2 (1,4-DCB), and
2-chlorobutadiene, 1,3 (,l3chloroprene) was undertaken with an emphasis on assessing the hazards of
these materials in the industrial situation. 1,3-DCB is a by-product in the production off-chloroprene
from the acetylene route, with 1,4-DCB is an intermediate in the production of 83-chloroprene from the
butadiene route, the production route used in the U. S. Presented in the review is a summary ofthe acute
toxicity including mutagen testing, skin, eye, and inhalation testing of these compounds. In addition,
subacute inhalation testing, embryotoxicity, teratogenicity, and carcinogenicity are also reviewed where
the information is available.
This paper is a review of the toxicity of 2-chloro-
butadiene-1,3 (,3-chloroprene), 1,3-dichloro-
butene-2 (1,3-DCB), and 1,4-dichlorobutene-2
(1,4-DCB).
Table 1 summarizes the interrelationship of
1,3-DCB, 1,4-DCB, and 8-chloroprene. /3-Chlo-
roprene canbe producedfrom two starting materials,
either acetylene with 1,3-DCB being a major by-
product or from butadiene with 1,4- and 3,4-DCB as
major intermediates. For many years the acetylene
route was used in the United States, but at present
only the butadiene route is used. Both routes are in
use in Europe and Japan, while in the U.S.S.R. only
the acetylene route is used.
Table 1. Production of 8-chloroprene.
Starting material
Acetylene
Butadiene
Major by-product
or intermediate
1,3-Dichlorobutene-2
1,4-Dichlorobutene-2
3,4-Dichlorobutene-l
Table 2 is a review of the toxicity of 1,3-DCB.
1,3-DCB has been tested for mutagenicity in the
Ames-type system and found to be negative in
*Haskell Laboratory, Central Research and Development
Department, E. I. du Pont de Nemours and Company Inc.,
Wilmington, Delaware 19898. Present address: Celanese Corpo-
ration, 1211 Avenue of the Americas, New York, N. Y. 10036.
Salmonella strains and "inconclusive" in activated
yeast systems (unpublished Du Pontdata). The LC50
in rats for a4-hrinhalation exposure is 546 ppm + 40.
The kidney, lung, liver, spleen, and thymus were
target organs following an acute inhalation exposure
(1). 1,3-DCB is also a lacrimator and is irritating to
the skin. 1,3-DCB is also reported to cause distur-
bance in carbohydrate metabolism and morphologi-
cal changes in the peripheral blood (2). Repeated
inhalation exposure in rats for 3-6 months, at ap-
proximately 20 ppm, showed capillary damage and
effects on the kidney, liver, and spleen (3, 4).
Table 2. Toxicity of 1,3-dichlorobutene-2.
Test Result
Mutagen test Inconclusive
Single exposure (inhalation)
Rat LC50 (4 hr) 546 (506-590 ppm)
Kidney, lung, liver, spleen
and thymus effects
Rabbit skin Irritating
Rabbit eye Lacrimator
Multiple exposure (inhalation)
Rat (3-6 mos.) 2 ppm No effect
Rat (3-6 mos) 20 ppm Capillary, kidney, liver,
spleen effects
Table 3 summarizes some ofthe toxicity informa-
tion on 1,4-DCB. 1,4-DCB is a mutagen in the Ames
system (unpublished Du Pont data). It is acutely
December 1977 269toxic with 4-hr LC50 value of86 ppm in rats (1). Its
oral LD50 in rats is 89 mg/kg (5). The LD50following
skin exposure in rats is 0.62 ml/kg (5). 1,4-DCB is a
very severe eye and skin irritant and will cause
bums, particularly in the eyes, that result in irrever-
sible eye damage (unpublished Haskell Laboratory
data).
Table 3. Toxicity of 1,4-Dichlorobutene-2.
Test Result
Mutagen Positive
Single exposure (inhalation)
Rat LC50 (4 hr) 86 (77-96) ppm
Hemorrhage in lungs,
liver, and spleen
Single exposure (oral)
Rat LD50 89 (41-196) mg/kg
Single exposure (skin)
Rat LD50 0.62 (0.47-0.81) ml/kg
Erythema, edema
Single exposure (eye) Severe burn, permanent
damage
Table 4 shows a summary of the results of two
inhalation tests, the first is a 2-week subacute expos-
ure by inhalation atlevels of0.1 or 10ppm inrats and
hamsters. At 10 ppm in rats, the following effects
were seen: growth retardation and inflammation of
the respiratory tract. No effects were seen in rats at
0.1 ppm. No effects were seen in hamsters following
exposure at either level in this study. In addition to
the 2-week subacute, a 4-week inhalation range-
finding study in rats (5 days/week, 6 hr/day) has also
beenconducted on 1,4-DCB at0.5, 2, 8, and 12 ppm.
The lowest effect level observed was 8 ppm. The
pathologic effects of 1,4-DCB are similar to that re-
ported in the two-week inhalation study with the
major effect of the respiratory tract (unpublished
Haskell Laboratory data).
Table 4. Toxicity of 1,4dichlorobutene-2 by repeated
exposure (inhalation) in the rat.
Duration Level, ppm Result
10 day 0.1 No effect
10 Growth retardation,
inflammation ofrespiratory
tract; no effect on
hamsters
4 weeks 0.5 No effect
2.0 No effect
8.0 Dose-related effects on
12.0 tracheal epithelium,
hematologic change
for a lifetime, no treatment-related increase in
tumors was observed. No treatment-related increase
in tumors was seen following an initiator-promotor
study in mice [1,4-DCB was used as the initiatorand
the promotor was 7,12-dimethylbenzan-
thracene (DMBA)]. Intraperitoneal injections of
1,4-DCB, once weekly for a lifetime in mice, also
showed no significant increase in tumors. Subcu-
taneous injection of 1,4-DCB, once a week for a
lifetime in mice, however, did result in aslight statis-
ticalincrease in tumors, with 3/30 mice showinglocal
sarcomas at the injection site.
Table 5. Chronic studies with 1,4-dichlorobutene-2 (mice).a
Test Result
Skin
Lifetime painting No treatment-related
3 x weekly increase in tumors
Initiator-promotor No treatment-related
increase in tumors
Intraperitoneal
Lifetime, No treatment-related
once weekly increase in tumors
Subcutaneous
Lifetime, 3/30 Local sarcomas
once weekly
aData from Van Duuren (6).
1,4-DCB is being studied in a 90-day inhalation
study in rats and a lifetime study in rats (6 hr/day, 5
days/week). These studies are being conducted at
levels of 0.5 and 5 ppm (unpublished Haskell
Laboratory data).
The rest of this review will be devoted to
,f-chloroprene. Figure 1 shows the chloroprene
generation-exposure system that was described in a
paper published in 1936 by von Oettingen et al. (7).
This 1936 papercovers quite an extensive evaluation
ofthe toxicity ofchloroprene. There are two things
about this generation-exposure system that should
be pointed out that are germane. First, the exposure
chamber levels of f3-chloroprene were not deter-
mined by analytical measurements but by weighing
the cylinder before and after exposure. The weight
change in the cylinder is divided by the number of
hours of exposure to get the average concentration
per hour. Secondly, the ,8-chloroprene was gener-
ated by the passage ofair through the cylinder. Con-
tinuous exposure to air results in chemical change to
,8-chloroprene and this could cause problems in try-
ing to assess the toxicity of chloroprene.
Table 6 shows von Oettingen's mortality data fol-
lowing the inhalation off8-chloroprene in rats. The
air concentration values were nominal values and
were not actual analytical measurements. It is obvi-
ous that alethal level ofchloroprene cannot be accu-
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Table 5 summarizes the chronic data on 1,4-DCB
generated by Van Duuren et al. (6). When 1,4-DCB
was applied to the skin ofmice, three times a week
270rately determined. At 1 mg/1, approximately 280
ppm, 25% mortality was observed; but at 6 mg/l
(1680 ppm), 10 mg/l (2800 ppm), and 14.8 mg/l (4100
ppm) no mortality was observed. Looking back at
these observations in light oftoday's knowledge, it is
quite possible that these differe4nces in mortality
could be related to inaccurately determined chlorop-
rene chamber concentrations, or more likely to
change in the sample due to its age and exposure to
air.
FIGURE 1: B-Chloroprene generation-exposure system (7).
Table 6. Effect of chloroprene inhalation on
mortality in rats (8 hr).a
Concentration,
mg/l. Mortality, %
0.4 0
1.0 25
1.9 0
2.2 100
6.0 0
6.3 100
8.4 50
10.0 0
14.8 0
21.1 100
aData from von Oettingen et al. (7).
Table 7 is also from von Oettingen's 1936 paper
and shows the effect of chloroprene on reproduc-
tion in rats and mice. In this case, the exposed
males were bred to unexposed virgin females. Here
again, this same unpredictable pattern in response
is observed-no indication of a detrimental effect
on reproduction at certain chloroprene exposure
levels, while lower levels show a definite effect on
reproduction. There also appears to be a pro-
nounced species difference. I point these data out
because von Oettingen's work was done in 1936 and
is the basis for much of the early knowledge of
the toxicity of chloroprene. For its day, von
Oettingen's work contained some very good infor-
mation, and its general conclusion is still
correct-chloroprene is a toxic material and should
be handled with caution.
Table 7. Effect ofinhalation of chloroprene
on male reproduction.a
Rat Mouse
Concn, % offemales Concn, % offemales
mg/I. with litter mg/I. with litter
0.434 50 0.042 0
1.074 0 0.271 50
1.088 33 0.414 0
1.095 0 0.429 100
2.223 0 0.434 100
6.035 50 0.541 0
8.421 0
10.000 67
16.983 33
aData from von Oettingen et al. (7).
The next significant paper on the toxicity of
chloroprene is the work reported by Nystrom in
1948 (8). This paper covers some significant animal
studies on chloroprene and is also a very thorough
review of the published chloroprene studies up to
that time. In addition to animal work, Nystrom de-
scribes some human experimental work on chloro-
prene. There is one salient point from Nystrom's
animal study that requires examination.
Nystrom conducted a subcutaneous acute test
with two different samples, one sample which he
called "fresh" chloroprene appeared to be freshly
distilled, the other sample was aged or "oxidized"
chloroprene. There is no description of storage
conditions. The data that point out the differences
in the animal's response to these two different types
ofchloroprene are shown inTable 8. The numberof
animals used (20/level) is sufficiently large to get a
good evaluation. There is adefinite difference in the
mortality associated with the different "types" of
chloroprene used.
,8-Chloroprene dimerizes readily at ambient
temperatures to form several cyclic compounds.
The product ofoxidation of,8-chloroprene, even at
Table 8. Effect of chemical state ofchloroprene sample on
mortality in mice following subcutaneous injection.a
Dose, ulIg "Oxidized" Nonoxidized
body weight % mortality % mortality
0.125 0 0
0.25 30 15
0.5 40 35
1.0 90 50
2.0 95 55
4.0 90 55
8.0 100 65
aData from Nystrom (8).
December 1977 271low temperatures, yields an unstable copolymer
with which oxygen is formed by both 1,3 and 1,4
addition. The polyperoxides formed range in
molecular weight up to 5000. The autoxidation of
chloroprene is faster than autoxidation of dimers,
so the main products ofoxidation are polyperoxides
(10). Therefore, in the manufacture of polychloro-
prene, /3-chloroprene is freshly distilled under vac-
uum and is stored at -10°C under nitrogen before
use. Because of its reactivity, chloroprene is nor-
mally used in an industrial situation within 24 hr
after distillation.
In von Oettingen's 1936 study (7), no care to pre-
vent oxidation was taken. von Oettingen's note-
book has been reviewed in the hope that it could be
discovered when fresh material was placed into his
generation system. In this regard, no information
could be found. The age or oxidized state of the
chloroprene used might explain the varied response
pattern seen by von Oettingen.
Table 9 shows a summary of some more recent
studies on chloroprene. Chloroprene has been sub-
jected to the Ames mutagen test several times. The
first test results were negative (unpublished Du
Pont data). Bartsch et al. (11), however, reported
that chloroprene is a mutagen in Salmonella strain
TA 100. In another more recent Ames test,
,8-chloroprene was positive in Salmonella strain TA
1535, but not in TA 100 (unpublished Du Pont
data). However, chloroprene dimers, which are
products of aging, are mutagens (unpublished Du
Pont data). The age of oxidation state of the sam-
ples tested for mutagenicity is not known in all
cases.
Table 9. Toxicity of chloroprene.
Test Result
Mutagen Questionable
Single exposure (inhalation)
ALC (4 hr, rat) 2300 ppm
Single exposure (oral)
LD50 (rat) 251 mg/kg
LD50 (mouse) 260 mg/kg
Class B poison Negative, all routes
Some of the more recent acute toxicity data on
,8-chloroprene show that the approximate lethal in-
halation dose ofchloroprene in rats is 2,300 ppm for
a 4-hr exposure (12). The oral LD50 in rats is 251
mg/kg and in mice the LD50 is 260 mg/kg (13).
Chloroprene is not classified as a Class B poison by
any route of exposure (unpublished Haskell
Laboratory data).
Table 10 shows a summary ofthe conclusions of
several different embryotoxicity and teratogenicity
studies with 3-chloroprene (14, 15). In the Russian
studies, done at levels as low as 1 ppm chloroprene,
both embryotoxic and teratogenic effects were re-
ported. No details of how the material was gener-
ated were found nor have inquiries to the authors
been productive in elucidating this information.
Table 10. Embryotoxicity and teratogenicity of 8-chloroprene.
Test Dose Result
Inhalation (rat)
U.S.S.R. I ppm Embryo deaths, hydro-
cephaly, hemorrhages
in fetus
U. S. 1, 10, 25 ppm No embryotoxic or
teratogenic effects
Oral (rat)
U.S.S.R. 0.5 mg/kg Preimplantation losses
Decreased fetal weight
and length
In the study by Culik et al. (16), pregnant rats were
exposed to f3-chloroprene levels of 1, 10, or 25 ppm.
The experimental conditions used, as far as exposure
times during gestation and length of exposure day,
were exactly the same as those reported in the Rus-
sian studies. In the experiment by Culik et al. (16),
the chloroprene was freshly distilled and kept on dry
ice or in a freezer until used. Each day a new, fresh
sample was used. As can be seen from Table 10, the
conclusions are not consistent with the Russian
studies. A preliminary, male reproduction study
conducted at the same time at 25 ppm also showed
no effect on male reproduction. The products ofoxi-
dation or aging of chloroprene may be a possible
explanation of the difference between the U.S.S.R.
and U.S. studies.
There have been two recent 4-week (6 hr/day, 5
days/week) range-finding inhalation experiments
Table 11. Repeated inhalation exposure to 3-chloroprene
(4 weeks, 5 days/week, 6 hr/day).
Concn,
Species ppm Result
Rat 39 Slight growth depression and
behavioral effect
161 Loss of hair, growth retardation,
liver damage
625 Loss ofhair, growth retardation,
liver damage, slight effect,
kidney, spleen, adrenal
Hamster 39 Slight irritation and restlessness.
162 Growth retardation, irritation,
liver damage
627 Death
Environmental Health Perspectives 272Table 12. Chronic studies (lifetime) with 8(3chloroprene.a
Route Species Skin Agent Dose Result
Skin Mouse Chloroprene 2/wk, 6 mo. No tumors
Chloroprene 2/wk, 6 mo., DMBA 5 x No tumors
DMBA 2/wk, 6 mo. 92% skin tumors
Subcutaneous Rat Chloroprene 400 mg/kg, 10 x No tumors
Chloroprene 200 mg/kg, 50 x No tumors
Chloroprene 200 mg/kg, 50 x + 0.5 mg DMBA, 1 x 57% tumors
DMBA only 1 x 64% tumors
Oral Rat Chloroprene 200 mg/kg, 2/wk, 6 mo. No tumors
aData from Zilfjan (17).
with f3-chloroprene in rats and hamsters (12). The
results of these experiments are summarized in
Table 11. These range-finding inhalation studies
were done to help select ,3-chloroprene levels for
chronic inhalation tests in rats and hamsters follow-
ing chloroprene exposure at the high level. In the
hamster study, death was observed after one expo-
sure. In the rats, mortality was also observed during
the 4-week period of the test as well as severe liver
and kidney effects. The animals that died showed
lung changes. Rats and hamsters exposed to the mid
level showed liver effects and growth retardation.
Alopecia in the rats was also observed at both the
mid and high level. Even at 39 ppm, the lowest level,
slight growth retardation and some restlessness were
observed. In general, the 39 ppm chloroprene level
was assessed to be a minimum-effect level.
Table 12 shows a summary of some of the recent
chronic work conducted on ,/-chloroprene by Zilfjan
et al. (17). This includes a ,8-chloroprene skin paint-
ing study which produced no tumors and a combina-
tion of chloroprene and DMBA in a skin painting
experiment in which no tumors were seen, although
DMBA by itself produced a significant number of
tumors following skin painting.
Zilfjan et al. (17) also reported that 8-chloroprene
does not produce tumors following subcutaneous
administration. In a second subcutaneous study, the
exposure to a combination of chloroprene and
DMBA showed a significant tumor incidence, but
the tumor rate was similar to that seen in animals
treated with DMBA only.
Zilfjan et al. (17) also reported no tumor produc-
tion in a chronic oral study with /8-chloroprene. In a
chronic rat inhalation study being conducted in the
Netherlands, at 10 and 50 ppm chloroprene, no
tumors have been seen grossly and the mortality has
been negligible after one year (unpublished Du Pont
data). A chronic inhalation hamster study at 10 and
50 ppm chloroprene has also been started in the same
laboratory.
This review is a summary ofwhat is known about
the toxicity of 1,3-DCB, 1,4-DCB, and /8-chloro-
prene. Several studies are ongoing, and the outcome
of these studies will certainly add to our knowledge
of the safety or hazards of these compounds.
NOTES ADDED IN PROOF
Recently conducted bacterial mutagen tests (Ames) at Haskell
Laboratory have shown ,3-chloroprene to give a positive re-
sponse inTA 1535 and TA 100inboth activated and nonactivated
systems.
After 12 months exposure to nominal airborne concentration
of 1,4-DCB of5 ppm, there is a statistically significant increase in
malignant nasal tumors in rats exposed at this level. Rats ex-
posed at the lower level of 0.5 ppm have shown no adverse
affects.
This work was sponsored in part by the Joint Industry Commit-
tee on Chloroprene (E. I. du Pont de Nemours and Co., Bayer
A. G., British Petroleum Chemicals, Ltd., and Denki Kagaku
Kogyo Kabushiki Kaisha).
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